IGF1 and metabolic dysfunction-associated steatotic liver disease: Elevated levels of GH, and decreased levels of IGF-I and IGFBP-3, suggesting a presence of GH resistance, were associated with the severity of the disease in patients with NAFLD but not in patients with HCV-related chronic liver disease [40].